# AOD-9604 and the hGH Fragment 176-191 Explained

> AOD-9604 and the hGH fragment 176-191 explained: how this C-terminal growth-hormone fragment inhibits fat synthesis and spares the GH receptor, with the mechanism cited.

From the membrane signal to the enzyme it switches off — the receptor-sparing mechanism, traced and cited.

## The short version

AOD-9604 and the **hGH fragment 176-191** are essentially the same idea: a small piece taken from the tail of human growth hormone, rebuilt in the lab. Growth hormone (hGH) is a large hormone that does many jobs — building tissue, raising the growth signal IGF-1, and handling fat. Researchers traced the fat job to one short region near the end of the hormone, around residues 176–191. AOD-9604 is that region, copied and slightly tweaked. Here is the clever part: this fragment can act on fat cells *without* switching on the growth-hormone receptor, so it does not raise IGF-1. In animals, it tells fat cells to make less new fat (by blocking an enzyme called ACC) and to burn more (by raising beta-3 receptors). The mechanism is well mapped in animals; the human fat-loss payoff never materialized. Below, the mechanism step by step.

## From residues 176-191 to a synthetic peptide

The numbering can be confusing, so here it is plainly. The fat-metabolizing activity of human growth hormone was localized to its C-terminal region, around residues 176–191 [14]. AOD-9604 is the synthetic version of that stretch — specifically modeled on residues 177–191 with an added N-terminal tyrosine, which is why it is described both as the **hGH fragment 176-191** and as `Tyr-hGH(177-191)` [3]. The internal disulfide bridge between its two cysteines reproduces the loop the same region forms in the intact hormone.

What makes the fragment useful is what it leaves behind. Full growth hormone binds the growth-hormone receptor and triggers IGF-1 production and growth signaling. The hGH fragment 176-191 does not engage that receptor and does not raise circulating IGF-1 [3]. That separation — fat effect kept, growth/IGF-1 effect dropped — is the entire design rationale.

## The membrane signal and the enzyme it switches off

Mechanistically, the hGH fragment 176-191 works at the fat-cell membrane. Human growth hormone and its C-terminal part-sequence (hGH 172–191) inhibit acetyl-CoA carboxylase (ACC) — a rate-limiting enzyme in fatty-acid synthesis — by interacting with adipocyte and hepatocyte plasma membranes and releasing a second messenger that increases the enzyme's phosphorylation [4]. In plain terms: the fragment touches the outside of the fat cell, an internal signal is released, and the cell's fat-building enzyme is turned down, so it makes less new fat. This is the *antilipogenic* action — suppressing the formation of new fat — that the foundational literature emphasizes.

Metabolic studies confirmed this activity belongs to the synthetic C-terminal domain itself [3], and early work mapped related effects on glucose transport in rat adipocytes [8]. The mechanism is, in short, a clean membrane-to-enzyme relay characterized across cell and rodent models.

## Beta-3 receptors, fat oxidation, and the limits of the model

The second mechanistic arm runs through the beta-3 adrenergic receptor (beta3-AR). In obese mice, chronic AOD-9604 up-regulated beta3-AR RNA in white adipose tissue, and the chronic weight-reducing effect required functional beta3-AR signaling — while acute increases in energy expenditure and fat oxidation persisted even without it [1]. A companion study confirmed increased fat oxidation and weight loss in obese mice with the C-terminal fragment [2].

The honest limit: this is a mouse, rat, and cell-model mechanism [3]. It is well characterized and reproducible in animals, but it did not translate into significant human weight loss in the pivotal trial [5][14]. The hGH fragment 176-191 is best understood as a beautifully traced preclinical mechanism whose human efficacy remains unproven — which is exactly how this digest presents it.

---

A forward-looking digest of the published science — bright on the mechanism, honest about the null result.